As shown in Figure 4A, significantly greater hypermethylation of the SATB2 promoter was detected in CRC tissues (43/62, 69.4%) than in normal colorectal tissues (15/62, 24.2%) (Supporting Information S1: Table 1). Here, SATB2 is linked to colorectal carcinoma.